Ask most people where their health care money goes and they’ll say doctors and hospitals. It’s a reasonable guess. It’s also increasingly wrong.
More and more, the answer is the pharmacy counter. Prescriptions now make up a big and fast-growing share of health spending — averaging close to a quarter of the total, and for some large employers creeping toward half. And here’s the strange part: a tiny group of drugs drives most of it. The complex “specialty” medications — the ones for conditions like cancer, autoimmune disease, and rare disorders — are only about 2% of prescriptions filled, but roughly 52% of the total drug spend.
The middleman most people have never heard of
Between you, your plan, and the pharmacy sits a company you probably can’t name: a PBM, short for Pharmacy Benefit Manager. PBMs decide which drugs your plan covers, negotiate the prices, and set what you actually hand over at the counter. A few big ones handle most of the market.
The trouble, in plain terms, is that how they make their money has always been hard to see. Two practices in particular:
- Spread pricing — the PBM charges your plan more for a drug than it pays the pharmacy, and quietly keeps the difference.
- Rebates — drugmakers pay the PBM rebates that are supposed to bring costs down, but how much of that actually reaches your plan (instead of staying with the PBM) has long been a black box.
What’s actually new in 2026
This is the part worth paying attention to, whoever you are. Early in 2026, Congress passed the first serious overhaul of PBM rules in about 20 years. Among other things, PBMs now have to hand employers regular, detailed reports on spread pricing and rebates — pulling back a curtain that used to stay shut. Federal regulators pushed in the same direction.
In plain English: the people paying for coverage are finally getting the information to see what they’re really being charged — and to push back.
Why it matters even if you just fill a prescription
Because these hidden mechanics can decide what you pay at the register. When rebates don’t make it back to the plan, or a drug gets parked on a pricey tier, you can end up paying more — sometimes a lot more — for the exact same medication. A plan built on a clearer, more transparent deal usually means lower, steadier costs for the people actually using it.
You don’t have to become an expert in any of this. The useful thing to walk away with is simple: prescriptions are now one of the biggest and most confusing pieces of health coverage, a tiny slice of drugs drives most of the cost, and 2026 is the year it’s finally getting easier to see what’s really going on behind the counter.